DiaMedica Therapeutics, Inc. (DMAC)
6.76
-0.26
(-3.70%)
USD |
NASDAQ |
Mar 20, 16:00
6.78
+0.02
(+0.30%)
After-Hours: 20:00
DiaMedica Therapeutics Shareholders Equity (Quarterly) : 51.62M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 18.47B |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 203.13M |
| BioMarin Pharmaceutical, Inc. | 6.087B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 57.05M |
| Total Liabilities (Quarterly) | 5.425M |
| Debt to Equity Ratio | 0.0052 |
| Current Ratio | 10.67 |
| Net Debt Paydown Yield | 0.01% |